104 related articles for article (PubMed ID: 26022121)
21. Preparation and characterization of chitosan/β-cyclodextrin nanoparticles containing plasmid DNA encoding interleukin-12.
Nahaei M; Valizadeh H; Baradaran B; Nahaei MR; Asgari D; Hallaj-Nezhadi S; Dastmalchi S; Lotfipour F
Drug Res (Stuttg); 2013 Jan; 63(1):7-12. PubMed ID: 23447042
[TBL] [Abstract][Full Text] [Related]
22. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity.
Si SY; Hu PZ; Huang YY; Ye J; Huang Y; Li ZS; Ge W; Li X; Qu P; Zhang XM; Sui YF
Biochem Biophys Res Commun; 2006 Aug; 347(1):208-14. PubMed ID: 16814254
[TBL] [Abstract][Full Text] [Related]
23. Protective efficacy of a Treponema pallidum Gpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2.
Zhao F; Wang S; Zhang X; Gu W; Yu J; Liu S; Zeng T; Zhang Y; Wu Y
Can J Microbiol; 2012 Feb; 58(2):117-23. PubMed ID: 22260167
[TBL] [Abstract][Full Text] [Related]
24. Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.
Cho HM; Rosenblatt JD; Tolba K; Shin SJ; Shin DS; Calfa C; Zhang Y; Shin SU
Cancer Res; 2010 Dec; 70(24):10121-30. PubMed ID: 21159634
[TBL] [Abstract][Full Text] [Related]
25. Hydrogel nanoparticle encapsulated plasmid as a suitable gene delivery system.
Rafieei A; Riazi-Rad F; Alimohammadian MH; Gazori T; Fatemi SM; Havaskary M
Tsitol Genet; 2015; 49(2):16-20. PubMed ID: 26030969
[TBL] [Abstract][Full Text] [Related]
26. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
Tang J; Yin R; Tian Y; Huang Z; Shi J; Fu X; Wang L; Wu Y; Hao F; Ni B
Vaccine; 2012 Feb; 30(6):1071-82. PubMed ID: 22178528
[TBL] [Abstract][Full Text] [Related]
27. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
[TBL] [Abstract][Full Text] [Related]
28. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070
[TBL] [Abstract][Full Text] [Related]
29. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.
Dou J; Wang Y; Wang J; Zhao F; Li Y; Cao M; Hu W; Hu K; He XF; Chu L; Jiang C; Gu N
Immunobiology; 2009; 214(6):483-92. PubMed ID: 19389515
[TBL] [Abstract][Full Text] [Related]
30. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
31. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
[TBL] [Abstract][Full Text] [Related]
32. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
Qu P; Ma JH; Zhang XM; Huang XJ; Yang XW; Yan-Fang S
Indian J Exp Biol; 2010 May; 48(5):436-43. PubMed ID: 20795360
[TBL] [Abstract][Full Text] [Related]
33. The Immunogenicity of CRISP1 Plasmid-Based Contraceptive Vaccine can be Improved When Using Chitosan Nanoparticles as the Carrier.
Luo J; Liu XL; Zhang Y; Wang YQ; Xu WM; Yang J
Am J Reprod Immunol; 2016 Jun; 75(6):643-53. PubMed ID: 27105782
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
Yamano T; Kaneda Y; Huang S; Hiramatsu SH; Hoon DS
Mol Ther; 2006 Jan; 13(1):194-202. PubMed ID: 16112911
[TBL] [Abstract][Full Text] [Related]
35. Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains.
Ferrone CR; Perales MA; Goldberg SM; Somberg CJ; Hirschhorn-Cymerman D; Gregor PD; Turk MJ; Ramirez-Montagut T; Gold JS; Houghton AN; Wolchok JD
Clin Cancer Res; 2006 Sep; 12(18):5511-9. PubMed ID: 17000687
[TBL] [Abstract][Full Text] [Related]
36. Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice.
Zhao F; Dou J; Wang J; Chu L; Tang Q; Wang Y; Li Y; Cao M; Hu W; Hu K; Feng He X; Gu N
Immunobiology; 2010; 215(2):89-100. PubMed ID: 19457579
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
Yin XL; Duan H; Peng ZP; Sun SL; Li SL
Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
[TBL] [Abstract][Full Text] [Related]
38. [Transformation activity and antigenicity of the human papillomavirus type 58 E6E7 fusion gene mutant].
Wang H; Yu JY; Li L
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):491-6. PubMed ID: 24257298
[TBL] [Abstract][Full Text] [Related]
39. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
[TBL] [Abstract][Full Text] [Related]
40. Mannosylated protamine as a novel DNA vaccine carrier for effective induction of anti-tumor immune responses.
Zeng Z; Dai S; Jiao Y; Jiang L; Zhao Y; Wang B; Zong L
Int J Pharm; 2016 Jun; 506(1-2):394-406. PubMed ID: 27106528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
